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Alopecia Areata Induced in C3H/HeJ Mice by Interferon-Gamma:
Evidence for Loss of Immune Privilege
To the Editor:
Hair follicles in both mice and humans may represent an
immune privileged site. The proximal follicular epithelium
does not express major histocompatibility complex (MHC)
class I or class II molecules (Paus et al, 1994, 1999), unless
induced by interferon-gamma (INF-g) (Gilhar et al, 1993).
This is the case in alopecia areata in both humans and C3H/
HeJ mice, where MHC class I and II are expressed by the
follicular epithelium. Paus et al (1994) have hypothesized
that induction of class I MHC on hair follicle epithelium and
associated loss of immune privilege is central to the
induction of alopecia areata. The goal of this study was
to the determine the role of loss of immune privilege in
the induction of alopecia areata. A secondary goal was
to develop a model of alopecia areata that could gene-
rate sufficient numbers of mice for use in therapeutic trials,
and which would be available to the general research
community.
There is a well-characterized model of alopecia areata in
C3H/HeJ mice, with many histologic and immunohistologic
features similar to the human condition (Sundberg et al,
1994). The mice develop spontaneous alopecia as they age,
with 20% of female mice developing alopecia by 12 mo
(Sundberg et al, 2003). It is possible to transfer this alopecia
to younger mice by grafting of involved skin (McElwee et al,
1998).
C3H/HeJ, C3H/HeN, and C57Bl/6J mice were obtained
from standard production colonies at Jackson Laboratories
(Bar Harbor, Maine). The mice were raised in the pathogen-
free animal facility of the B. Rappaport Faculty of Medicine,
Technion-Israel Institute of Technology. Animal care and
research protocols were in accordance with institutional
guidelines, and approved by the institutional committee on
animal use.
Mice were first shaved, to induce the anagen (growing
phase) of the hair cycle. They were then injected intrave-
nously with murine INF-g 2  104 U (Cytolab/Peprotech,
Rocky Hill, New Jersey) or saline for three consecutive days,
followed by injections every 7 d. This INF-g treatment was
previously shown to induce expression of MHC class I and
class II on follicular epithelium (Gilhar et al, 1993).
For the first experiment, there were four mice per group
(C3H/HeJ females; 8 wk of age). Hair regrowth following the
shaving was noted in both groups by day 22. Hair loss was
noted in the INF-g-injected mice on day 36 (three of four
mice). On day 64, complete hair regrowth was observed in
all INF-g treated mice, with the presence of white hairs. A
second wave of patchy hair loss was observed in the same
INF-g-treated (three of four) mice by day 86. The hair loss
was still present in (three of four) mice at day 252. No hair
loss was noted in the phosphate-buffered saline (PBS)-
treated mice.
For the second experiment, there were five mice per
group (C3H/HeJ females; 8 wk of age). Hair regrowth
following shaving was observed by day 23, and by day 46
hair loss was noted on the ventral surface of (four of five)
INF-g-treated mice, and none of the (zero of five) PBS-
treated mice. Mice were 3.1 mo of age at the time of hair
loss. There was complete hair regrowth in all (five of five)
INF-g-treated mice by day 60, with a second episode of
patchy hair loss around the head that started on day 63 in
the same (four of five) INF-g-treated mice. These mice
subsequently regrew hair by day 117. The combined data
for both experiments were hair loss in (seven of nine) mice
injected with INF-g, and (zero of nine) mice injected with
PBS, for a significance of po0.01 by w2.
Strains of mice that are not susceptible to alopecia
areata (C57Bl/6J and C3H/HeN) were also shaved, and
injected with INF-g or PBS (five mice per group) by the
above protocol. The C57Bl/6J mice received 11 injections
over 57 d, and the C3H/HeN mice received 13 injections
over 70 d. No hair loss was observed in any mice.
Figure1
Histology of injected mice. Histology of interferon-gamma (INF-g)-
treated mice (16, A; 40, B), and phosphate-buffered saline (PBS)-
treated mice (16, C; 40, D). Scale bar¼20 mm.
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INF-g-treated mice showed dystrophic hair follicles in
anagen, associated with intra- and peri-follicular mono-
nuclear cell infiltrates (Fig 1). Intra-follicular infiltrates were
predominantly CD8þ cells, and the peri-follicular infiltrates
were predominantly CD4þ cells (Fig 2). MHC class I and
MHC class II were expressed especially on the outer root
sheath, but also on the inner root sheath, and MHC class I
was also expressed on the hair bulb. There was strong
expression of interferon-inducible protein-10 (IP-10) on
follicular epithelium. IL-10 was weakly expressed on
follicular epithelium. IL-4 was expressed by some mono-
nuclear cells. These findings are consistent with those
previously reported for alopecia areata in C3H/HeJ mice
(McElwee et al, 2003), and are similar to those reported for
humans (Gilhar et al, 2003). In contrast, PBS-treated control
mice exhibited minimal to no infiltrate, and no dystrophic
anagen follicles. There was no expression of MHC class I
and II on proximal follicular epithelium, and cytokine
expression was limited to weak expression of IL-10 by
follicular epithelium.
Injection of INF-g accelerated the development of
autoimmune organ-specific disease (alopecia areata) in a
genetically susceptible mouse strain. This was associated
with expression of MHC class I and II in an immune
privileged site (proximal hair follicle epithelium), and
provides support for the hypothesis that loss of immune
privilege can induce organ-specific autoimmune disease in
a susceptible host.
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Figure 2
Lymphocyte infiltrate and cytokine production. CD8þ cells, CD4þ
cells, major histocompatibility complex (MHC) class I, MHC class II and
interferon-inducible protein-10 (IP-10) in mice treated with interferon-
gamma (INF-g) or phosphate-buffered saline (PBS).
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